Massachusetts Financial Services
PRLD icon

Massachusetts Financial Services’s Prelude Therapeutics PRLD Stock Holding History

Massachusetts Financial Services’s Portfolio PRLD Stock Details PRLD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-494,497
Closed -$630K – 913
2024
Q4 		$630K Sell
494,497
-55,033
-10% -$73K ﹤0.01% 836
2024
Q3 		$1.14M Buy
549,530
+27,155
+5% +$126K ﹤0.01% 789
2024
Q2 		$1.99M Buy
522,375
+14,226
+3% +$57.9K ﹤0.01% 748
2024
Q1 		$2.41M Sell
508,149
-2,600
-0.5% -$10.1K ﹤0.01% 721
2023
Q4 		$2.18M Buy
510,749
+470
+0.1% +$1.43K ﹤0.01% 720
2023
Q3 		$1.58M Buy
510,279
+889
+0.2% +$3.34K ﹤0.01% 743
2023
Q2 		$2.29M Sell
509,390
-5,158
-1% -$30.8K ﹤0.01% 695
2023
Q1 		$2.93M Sell
514,548
-423
-0.1% -$2.58K ﹤0.01% 685
2022
Q4 		$3.11M Buy
514,971
+1,678
+0.3% +$10.8K ﹤0.01% 687
2022
Q3 		$3.39M Buy
513,293
+34,768
+7% +$234K ﹤0.01% 677
2022
Q2 		$2.5M Sell
478,525
-3,594
-0.7% -$18.3K ﹤0.01% 698
2022
Q1 		$3.33M Buy
482,119
+13,322
+3% +$122K ﹤0.01% 708
2021
Q4 		$5.84M Sell
468,797
-3,449
-0.7% -$56.1K ﹤0.01% 693
2021
Q3 		$14.8M Buy
472,246
+97,080
+26% +$3.14M ﹤0.01% 641
2021
Q2 		$10.7M Buy
375,166
+94,002
+33% +$3.35M ﹤0.01% 669
2021
Q1 		$12.2M Sell
281,164
-3,023
-1% -$201K ﹤0.01% 651
2020
Q4 		$20.3M Sell
284,187
-233,824
-45% -$11.6M 0.01% 592
2020
Q3 		$15.6M Buy
+518,011
New +$14.6M 0.01% 591

Other funds holding PRLD

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
BCM
Boxer Capital Management San Diego, California $762M AUM 1,125.36% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Massachusetts Financial Services's PRLD Position: Q1 2025 in Review

Massachusetts Financial Services sold out of Prelude Therapeutics (PRLD) in Q1 2025, closing a stake of 494,497 shares — an estimated $630K sold.

Massachusetts Financial Services first reported a position in PRLD in Q3 2020 and held it in 18 quarters. The position peaked at $20.3M in Q4 2020. 59 funds tracked by Wall St. Rank hold PRLD as of Q1 2025.

  • Massachusetts Financial Services reported no remaining Prelude Therapeutics position as of Q1 2025 after selling out during the quarter.
  • Massachusetts Financial Services sold 494,497 Prelude Therapeutics shares in Q1 2025, an estimated $630K.
  • Massachusetts Financial Services first reported a position in Prelude Therapeutics in Q3 2020 and held it in 18 quarters.
  • Massachusetts Financial Services's Prelude Therapeutics position peaked at $20.3M in Q4 2020.
  • 59 funds tracked by Wall St. Rank held Prelude Therapeutics as of Q1 2025.

Based on Massachusetts Financial Services's 13F filing for Q1 2025, filed 2 May 2025.